$9.09
0.323.59%
Last update: Nov 11, 2:31 PM
ClearPoint Neuro Inc
CLPTNASDAQ
ClearPoint Neuro fell 49.6% from $17.40 to $8.77, behind the S&P 500's +9.8%. Its worst day was Sep 29 (−23.1%), and its low came Nov 6 at $8.60.
Nov 11, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
ClearPoint Neuro shares fell 22.0%, while the S&P 500 rose 0.1%.
−22.0% · S&P 500 +0.1%
EPS of $-0.23 missed the $-0.21 estimate on $10.4M revenue (est. $9.9M); FY revenue guidance of $52.0M–$56.0M against the $56.1M consensus.
Story events cover the past 12 months · Times ET
−13.9% · S&P 500 −1.4%
ClearPoint Neuro shares rose 15.3%, while the S&P 500 rose 1.0%.
+15.3% · S&P 500 +1.0%
EPS of $-0.32 missed the $-0.27 estimate on $12.1M revenue (est. $12.0M); FY revenue guidance of $52.0M–$56.0M against the $53.1M consensus.
+4.8% · S&P 500 +0.8%
ClearPoint Neuro shares rose 26.0%, while the S&P 500 fell 1.5%.
+26.0%, the year's best day, on 7M shares, the year's heaviest volume · S&P 500 −1.5%
ClearPoint Neuro closed at its highest level of the year, 11.7% above where the year started.
+5.1% · S&P 500 +1.6%
EPS of $-0.38 missed the $-0.28 estimate on $10.9M revenue (est. $12.8M); FY revenue guidance of $48.0M–$52.0M against the $53.2M consensus.
−16.3% · S&P 500 +1.8%
ClearPoint Neuro shares fell 23.1%, while the S&P 500 fell 0.2%.
−23.1%, the year's worst day · S&P 500 −0.2%
EPS of $-0.24 beat the $-0.32 estimate on $12.1M revenue (est. $12.3M); FY revenue guidance of $48.0M–$50.0M against the $49.2M consensus.
+1.2% · S&P 500 −0.4%
Where it ended: a close of $8.77 on Nov 10, 2026.
Nothing in the past 12 months.
All CLPT dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for CLPT and SPY from Benzinga historical bars. Not investment advice.
